Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device

References

• Lloyd-JonesDMWangTJLeipEPLifetime risk for development of atrial fibrillation: the Framingham Heart StudyCirculation200411091042104615313941
   PubMed Web of Science ®Google Scholar
• NieuwlaatRCapucciACammAJEuropean Heart Survey InvestigatorsAtrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial FibrillationEur Heart J200526222422243416204266
   PubMed Web of Science ®Google Scholar
• PistersRNieuwlaatRPrinsMHEuro Heart Survey InvestigatorsClinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart SurveyEuropace201214566667422223715
   PubMed Web of Science ®Google Scholar
• Van GelderICHagensVEBoskerHARate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study GroupA comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillationN Engl J Med2002347231834184012466507
   PubMed Web of Science ®Google Scholar
• WyseDGWaldoALDiMarcoJPAtrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) InvestigatorsA comparison of rate control and rhythm control in patients with atrial fibrillationN Engl J Med2002347231825183312466506
   PubMed Web of Science ®Google Scholar
• HaegeliLMCalkinsHCatheter ablation of atrial fibrillation: an updateEur Heart J20143532454245925053659
   PubMedGoogle Scholar
• WeerasooriyaRKhairyPLitalienJCatheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?J Am Coll Cardiol201157216016621211687
   PubMed Web of Science ®Google Scholar
• BoersmaLVCastellaMvan BovenWAtrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trialCirculation20121251233022082673
   PubMed Web of Science ®Google Scholar
• De BackerOArnousSIhlemannNPercutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an updateOpen Heart201411e00002025332785
   PubMedGoogle Scholar
• BlackshearJLOdellJAAppendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillationAnn Thorac Surg19966127557598572814
   PubMed Web of Science ®Google Scholar
• WatsonTShantsilaELipGYMechanisms of thrombogenesis in atrial fibrillation: virchow’s triad revisitedLancet2009373965815516619135613
   PubMed Web of Science ®Google Scholar
• Di BiaseLSantangeliPAnselminoMDoes the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? results from a multicenter studyJ Am Coll Cardiol201260653153822858289
   PubMed Web of Science ®Google Scholar
• LupercioFCarlos RuizJBricenoDFLeft atrial appendage morphology assessment for risk stratification of embolic stroke in patients with atrial fibrillation: a meta-analysisHeart Rhythm20161371402140927016474
   PubMed Web of Science ®Google Scholar
• CammAJLipGYDe CaterinaRESC Committee for Practice Guidelines (CPG); Document Reviewers2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm AssociationEuropace201214101385141322923145
   PubMed Web of Science ®Google Scholar
• JanuaryCTWannLSAlpertJSAmerican College of Cardiology/American Heart Association Task Force on Practice Guidelines2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm SocietyJ Am Coll Cardiol20146421e1e7624685669
   PubMed Web of Science ®Google Scholar
• LipGYEdwardsSJStroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysisThromb Res2006118332133316198396
   PubMed Web of Science ®Google Scholar
• EikelboomJWWallentinLConnollySJRisk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trialCirculation2011123212363237221576658
   PubMed Web of Science ®Google Scholar
• HylekEMEvans-MolinaCSheaCHenaultLEReganSMajor hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillationCirculation2007115212689269617515465
   PubMed Web of Science ®Google Scholar
• SudlowMThomsonRThwaitesBRodgersHKennyRAPrevalence of atrial fibrillation and eligibility for anticoagulants in the communityLancet19983529135116711719777832
   PubMed Web of Science ®Google Scholar
• LipGYThe role of aspirin for stroke prevention in atrial fibrillationNat Rev Cardiol201181060260621788962
   PubMed Web of Science ®Google Scholar
• MantJHobbsFDFletcherKBAFTA investigators; Midland Research Practices Network (MidReC)Warfarin vs aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trialLancet2007370958649350317693178
   PubMed Web of Science ®Google Scholar
• RashADownesTPortnerRYeoWWMorganNChannerKSA randomised controlled trial of warfarin vs aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)Age Ageing200736215115617175564
   PubMed Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSRE-LY Steering Committee and InvestigatorsDabigatran vs warfarin in patients with atrial fibrillationN Engl J Med2009361121139115119717844
   PubMed Web of Science ®Google Scholar
• PatelMRMahaffeyKWGargJROCKET AF InvestigatorsRivaroxaban vs warfarin in nonvalvular atrial fibrillationN Engl J Med20113651088389121830957
   PubMed Web of Science ®Google Scholar
• GrangerCBAlexanderJHMcMurrayJJARISTOTLE Committees and InvestigatorsApixaban vs warfarin in patients with atrial fibrillationN Engl J Med20113651198199221870978
   PubMed Web of Science ®Google Scholar
• GiuglianoRPRuffCTBraunwaldEENGAGE AF-TIMI 48 InvestigatorsEdoxaban versus warfarin in patients with atrial fibrillationN Engl J Med2013369222093210424251359
   PubMed Web of Science ®Google Scholar
• RuffCTGiuglianoRPBraunwaldEComparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsLancet2014383992195596224315724
   PubMed Web of Science ®Google Scholar
• WallentinLYusufSEzekowitzMDRE-LY investigatorsEfficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLancet2010376974597598320801496
   PubMed Web of Science ®Google Scholar
• KirchhofPBenussiSKotechaD2016ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEur Heart J Epub August 27, 2016
   Google Scholar
• MaddenJLResection of the left auricular appendix; a prophylaxis for recurrent arterial emboliJ Am Med Assoc1949140976977218152330
   PubMed Web of Science ®Google Scholar
• JohnsonWDGanjooAKStoneCDSrivyasRCHowardMThe left atrial appendage: our most lethal human attachment! Surgical implicationsEur J Cardiothorac Surg200017671872210856866
   PubMed Web of Science ®Google Scholar
• HealeyJSCrystalELamyALeft Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for strokeAm Heart J2005150228829316086933
   PubMed Web of Science ®Google Scholar
• WhitlockRPVincentJBlackallMHLeft Atrial Appendage Occlusion Study II (LAAOS II) (Left Atrial Appendage Occlusion Study II (LAAOS II)Can J Cardiol201329111443144724054920
   PubMed Web of Science ®Google Scholar
• WhitlockRHealeyJVincentJRationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) IIIAnn Cardiothorac Surg201431455424516797
   PubMedGoogle Scholar
• OdellJABlackshearJLDaviesEThoracoscopic obliteration of the left atrial appendage: potential for stroke reduction?Ann Thorac Surg19966125655698572768
   PubMed Web of Science ®Google Scholar
• BlackshearJLJohnsonWDOdellJAThoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillationJ Am Coll Cardiol20034271249125214522490
   PubMed Web of Science ®Google Scholar
• FumotoHGillinovAMOotakiYA novel device for left atrial appendage exclusion: the third-generation atrial exclusion deviceJ Thorac Cardiovasc Surg200813641019102718954645
   PubMed Web of Science ®Google Scholar
• SalzbergSPGillinovAMAnyanwuACastilloJFilsoufiFAdamsDHSurgical left atrial appendage occlusion: evaluation of a novel device with magnetic resonance imagingEur J Cardiothorac Surg200834476677018693117
   PubMed Web of Science ®Google Scholar
• SalzbergSPPlassAEmmertMYLeft atrial appendage clip occlusion: early clinical resultsJ Thorac Cardiovasc Surg201013951269127419880144
   PubMed Web of Science ®Google Scholar
• AilawadiGGerdischMWHarveyRLExclusion of the left atrial appendage with a novel device: early results of a multicenter trialJ Thorac Cardiovasc Surg201114251002100921906756
   PubMed Web of Science ®Google Scholar
• BalkhyHHChapmanPDArnsdorfSEMinimally invasive atrial fibrillation ablation combined with a new technique for thoracoscopic stapling of the left atrial appendage: case reportHeart Surg Forum20047635335515769703
   PubMed Web of Science ®Google Scholar
• NakaiTLeshMDGerstenfeldEPVirmaniRJonesRLeeRJPercutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine modelCirculation200210582217222211994258
   PubMedGoogle Scholar
• SievertHLeshMDTrepelsTPercutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experienceCirculation2002105161887188911997272
   PubMed Web of Science ®Google Scholar
• Cruz-GonzalezICubedduRJSanchez-LedesmaMLeft atrial appendage exclusion using an Amplatzer deviceInt J Cardiol20091341e1e318272242
   PubMed Web of Science ®Google Scholar
• ParkJWBethencourtASievertHLeft atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experienceCatheter Cardiovasc Interv201177570070620824765
   PubMed Web of Science ®Google Scholar
• TzikasAShakirSGafoorSLeft atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac PlugEuroIntervention201611101170117925604089
   PubMed Web of Science ®Google Scholar
• LeeRJBartusKYakubovSJCatheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: initial experience in a canine modelCirc Cardiovasc Interv20103322422920484100
   PubMed Web of Science ®Google Scholar
• BartusKHanFTBednarekJPercutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experienceJ Am Coll Cardiol201362210811823062528
   PubMed Web of Science ®Google Scholar
• AfzalMRKanmanthareddyAEarnestMImpact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devicesHeart Rhythm2015121525925281005
   PubMed Web of Science ®Google Scholar
• ChatterjeeSHerrmannHCWilenskyRLSafety and procedural success of left atrial appendage exclusion with the Lariat device: a systematic review of published reports and analytic review of the FDA MAUDE databaseJAMA Intern Med201517571104110925938303
   PubMed Web of Science ®Google Scholar
• LakkireddyDAfzalMRLeeRJShort and long-term outcomes of percutaneous left atrial appendage suture ligation: results from a US multicenter evaluationHeart Rhythm20161351030103626872554
   PubMed Web of Science ®Google Scholar
• LeeRJLakkireddyDMittalSPercutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): rationale and designAm Heart J201517061184119426678640
   PubMed Web of Science ®Google Scholar
• SievertHRasekhABartusKLeft atrial appendage ligation in nonvalvular atrial fibrillation patients at high risk for embolic events with ineligibility for oral anticoagulation. Initial report of clinical outcomesJACCCEP201516465474
   Google Scholar
• SickPBSchulerGHauptmannKEInitial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillationJ Am Coll Cardiol200749131490149517397680
   PubMed Web of Science ®Google Scholar
• HolmesDRReddyVYTuriZGPROTECT AF InvestigatorsPercutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trialLancet2009374968953454219683639
   PubMed Web of Science ®Google Scholar
• ReddyVYHolmesDDoshiSKNeuzilPKarSSafety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access RegistryCirculation2011123441742421242484
   PubMed Web of Science ®Google Scholar
• ReddyVYDoshiSKSievertHPROTECT AF InvestigatorsPercutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) TrialCirculation2013127672072923325525
   PubMed Web of Science ®Google Scholar
• ReddyVYSievertHHalperinJPROTECT AF Steering Committee and InvestigatorsPercutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trialJAMA2014312191988199825399274
   PubMed Web of Science ®Google Scholar
• ConnollySJEikelboomJJoynerCApixaban in patients with atrial fibrillationN Engl J Med2011364980681721309657
   PubMed Web of Science ®Google Scholar
• ReddyVYMöbius-WinklerSMillerMALeft atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)J Am Coll Cardiol201361252551255623583249
   PubMed Web of Science ®Google Scholar
• BoersmaLVSchmidtBBettsTREWOLUTION investigatorsImplant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registryEur Heart J201637312465247426822918
   PubMed Web of Science ®Google Scholar
• Viles-GonzalezJFKarSDouglasPThe clinical impact of incomplete left atrial appendage closure with the watchman device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation) substudyJ Am Coll Cardiol2012591092392922381428
   PubMed Web of Science ®Google Scholar
• WunderlichNCBeigelRSwaansMJHoSYSiegelRJPercutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiographyJACC Cardiovasc Imaging20158447248825882576
   PubMed Web of Science ®Google Scholar
• ReddyVYAkehurstRLArmstrongSOCost effectiveness of left atrial appendage closure with the watchman device for atrial fibrillation patients with absolute contraindications to warfarinEuropace201618797998626838691
   PubMed Web of Science ®Google Scholar
• ReddyVYAkehurstRLArmstrongSOAmorosiSLBeardSMHolmesDRJrTime to cost-effectiveness following stroke reduction strategies in AF: Warfarin versus NOACs versus LAA closureJ Am Coll Cardiol201566242728273926616031
   PubMed Web of Science ®Google Scholar
• AlliODoshiSKarSQuality of life assessment in the random-ized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillationJ Am Coll Cardiol201361171790179823500276
   PubMed Web of Science ®Google Scholar
• PapponeCAugelloGSalaSA randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF StudyJ Am Coll Cardiol200648112340234717161267
   PubMed Web of Science ®Google Scholar
• StabileGBertagliaESenatoreGCatheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multicentre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study)Eur Heart J200627221622116214831
   PubMed Web of Science ®Google Scholar
• SwaansMJPostMCRensingBJBoersmaLVAblation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility studyJ Am Heart Assoc201215e00221223316289
   PubMed Web of Science ®Google Scholar
• AlipourASwaansMJvan DijkVFAblation for atrial fibrillation combined with left atrial appendage closureJACC EP201516486495
   Google Scholar
• CalvoNSalterainNArguedasHCombined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillationEuropace201517101533154025935163
   PubMed Web of Science ®Google Scholar
• HeegerCHRilligALinTFeasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devicesHeart Rhythm20151271524153125769512
   PubMed Web of Science ®Google Scholar
• CammAJLipGYDe CaterinaR2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillationEur Heart J201233212719274722922413
   PubMed Web of Science ®Google Scholar
• VorselaarsVMVelthuisSSwaansMJPercutaneous left atrial appendage closure-An alternative strategy for anticoagulation in atrial fibrillation and hereditary hemorrhagic telangiectasia?Cardiovasc Diagn Ther201551495325774347
   PubMedGoogle Scholar